Timothy Mitchell
Oprichter bij SAREUM HOLDINGS PLC
Vermogen: 571 874 $ op 31-05-2024
Profiel
Timothy John Mitchell was the founder of Sareum Holdings Plc, where he held the title of Chief Executive Officer & Executive Director until his departure.
Sareum Holdings Plc was founded in 2003.
Dr. Mitchell's former positions include Director-Computational Chemistry at Cambridge Discovery Chemistry and Director-Structure Based Discovery at Millennium Pharmaceuticals Research & Development Ltd.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SAREUM HOLDINGS PLC
0.96% | 28-03-2024 | 1 032 561 ( 0.96% ) | 571 874 $ | 31-05-2024 |
Actieve functies van Timothy Mitchell
| Bedrijven | Functie | Begin |
|---|---|---|
| SAREUM HOLDINGS PLC | Oprichter | 01-08-2003 |
Eerdere bekende functies van Timothy Mitchell
| Bedrijven | Functie | Einde |
|---|---|---|
| Millennium Pharmaceuticals Research & Development Ltd. | Corporate Officer/Principal | - |
Cambridge Discovery Chemistry
 Cambridge Discovery Chemistry Miscellaneous Commercial ServicesCommercial Services Part of Signature BioScience, Inc., Cambridge Discovery Chemistry provides chemistry research services. Cambridge Discovery Chemistry was acquired by Signature BioScience, Inc. from Millennium Pharmaceuticals, Inc. on July 16, 2001. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SAREUM HOLDINGS PLC | Miscellaneous |
| Bedrijven in privébezit | 2 |
|---|---|
Cambridge Discovery Chemistry
Cambridge Discovery Chemistry Miscellaneous Commercial ServicesCommercial Services Part of Signature BioScience, Inc., Cambridge Discovery Chemistry provides chemistry research services. Cambridge Discovery Chemistry was acquired by Signature BioScience, Inc. from Millennium Pharmaceuticals, Inc. on July 16, 2001. | Commercial Services |
| Millennium Pharmaceuticals Research & Development Ltd. |
